Crossmark

N6-methyladenosine modification of MEF2A weakens cetuximab sensitivity in colorectal cancer via PD-L1/SOX12 axis

Published Online: 2025-07-01

Authors

Gao, Cao

He, Jiajia

Zhao, Jiemin

Ni, Xuefeng

Xu, Yanjie https://orcid.org/0000-0002-3153-7359
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 20 November 2024

Revised: 21 May 2025

Accepted: 13 June 2025

First Online: 1 July 2025

Competing interests

: The authors declare no competing interests.

: The present research was approved by the Ethics Committee of Soochow University, and written consent was gained from all individuals. Animal experiments had been approved by the Animal Care and Use Committee of Soochow University.

Document is current